Shares of Gland Pharma hit a low of Rs 923 on BSE, down 13.40 per cent. The stock had fallen 20 per cent in the previous session. The two-day fall stood at 31.04 per cent.
The drugmaker reported a 72 per cent YoY drop in net profit to Rs 79 crore in Q4FY23 due to a production shutdown at one of its facilities in Telangana and soft demand.